Atrium initiates a strategic re-evaluation process for its active ingredients and specialty chemicals division

    QUEBEC, Dec. 18 /CNW Telbec/ - Atrium Innovations Inc. "Atrium"
(TSX: ATB) today announced its decision to undertake a strategic re-evaluation
process of its Active Ingredients and Specialty Chemicals division.
    This strategic re-evaluation process is primarily motivated by the
following factors:

    - Atrium's intention to focus on its activities and resources in the
      Health and Nutrition sector to give the Company all the leverage it
      needs to achieve its strategic objectives in the sector, including its
      goal of becoming a world leader in this field;
    - the promising business development outlook for Atrium in the nutrional
      supplements sector, which offers many accretive acquisition
      opportunities for the Company;
    - due to the numerous development projects underway within Atrium's two
      divisions, it has become desirable that each division be supported by
      its own capital structure to allow them to carry out their respective
      development plans in an optimal manner.

    "The objective of this strategic process is to strengthen Atrium with a
targeted vision and development strategy in the high potential nutritional
supplements market. Atrium intends to play the role of a consolidator in this
highly fragmented sector, through energetically pursuing its successful
acquisitions program. In addition, the ageing of the population and growing
interest of consumers for alternative solutions to maintain good health will
be two powerful growth drivers for this market in the future. We believe that
our approach will allow us to optimize the creation of shareholder value,"
said Mr. Pierre Fitzgibbon, President and Chief Executive Officer of Atrium.

    About Atrium

    Atrium Innovations Inc. is a recognized leading developer, manufacturer
and marketer of science-based products for the cosmetics, pharmaceutical,
chemical and nutrition industries. The Company focuses primarily on growing
segments of the health and personal care markets which are benefiting from the
trends towards healthy living and the ageing of the population. Atrium markets
a broad portfolio of active ingredients, specialty chemicals and health and
nutrition finished products through its highly specialized sales and marketing
network in more than 50 countries, primarily in North America, Europe and
Asia. Atrium has over 600 employees and operates four manufacturing
facilities. Additional information about Atrium is available on its Web site

    Cautionary Note and Forward-Looking Statements

    This press release contains certain forward-looking statements with
respect to the Company. These forward-looking statements, by their nature,
necessarily involve risks and uncertainties that could cause actual results to
differ materially from those contemplated by these forward-looking statements.
The Company considers the assumptions on which these forward-looking
statements are based to be reasonable, but cautions the reader that these
assumptions regarding future events, many of which are beyond its control, may
ultimately prove to be incorrect since they are subject to risks and
uncertainties that affect the Company. For additional information with respect
to these and other factors, see the Company's quarterly and annual filings
with the Canadian securities commissions. The Company disclaims any intention
or obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, other than as required
by law.

For further information:

For further information: Investor Relations: Pierre Fitzgibbon,
President and Chief Executive officer, (418) 652-1116,; Media Relations: Frédéric Tremblay, HKDP, (514)
395-0375, ext. 234,

Organization Profile

Atrium Innovations Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890